1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Closes May 15, 2026 at 2:00 PM Copenhagen time. Stored deadline was null.
AMR Research Call is a grant program from the Novo Nordisk Foundation under its Infectious Diseases Catalyst Grants initiative, providing catalytic funding for exploratory, use-inspired, and innovative research projects with exceptional potential for direct impact on global challenges in human infectious diseases.
In 2026, the program focuses on two scientific themes: Novel AMR Tools to combat antimicrobial resistance, prioritizing pathogens on the WHO Bacterial Priority Pathogen List 2024, and Pandemic Influenza research addressing viral infectivity, transmission, and disease severity. A total of DKK 60 million is available.
Projects led by a principal investigator based in a Nordic country can receive up to DKK 4 million over three years, while collaborative projects with an international co-applicant can receive up to DKK 7 million. Eligible applicants must hold a position at assistant professor level or above at a university, hospital, or non-profit research institution in a Nordic country. The application deadline is May 15, 2026.
Get alerted about grants like this
Save a search for “Novo Nordisk Foundation” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Infectious Diseases Catalyst Grants - Novo Nordisk Fonden Infectious Diseases Catalyst Grants 15 May 2026 2:00pm (Copenhagen time) Rules, grant administration and FAQ Projects led by a PI based in a Nordic country can be awarded up to 4 million up to 3 years. Collaborative projects involving a Nordic PI and an international co-applicant can be awarded up to DKK 7 million. International, Nordic Countries (incl.
Denmark) Research Leaders (Established/Prof.), Research Leaders (junior/non-tenured), Research Leaders (Mid-career/Associate Prof.) Bioscience and Basic Biomedicine, Clinical and Translational Medicine, Infectious Diseases Committee for Infectious Diseases (CID) Grant Specialist, Grant Management The purpose of the “Infectious Diseases – Catalyst Grants” programme is to provide catalytic funding for exploratory, use-inspired, and innovative research projects that have exceptional potential for future direct impact on global challenges within human infectious diseases .
In 2026, projects submitted to this call for applications must be within one of the two scientific themes , namely Novel AMR tools or Pandemic Influenza . The main applicant must be anchored and have their primary employment and research group at a university, hospital, or other non-profit research institution in a Nordic country.
The main applicant must be employed at the institution they are applying from and must be guaranteed their own salary for the entire project period. The main applicant must be at assistant professor, associate professor, or professor (or similar levels). Applications from postdocs or Ph.
D. students are not accepted. Early career-stage group-leaders as well as women and other groups that have been historically under-represented in scientific research are strongly encouraged to apply and to be included as co-applicants.
A main applicant (or a co-applicant ) can only submit/be part of one application to the 2026 “Infectious Diseases – Catalyst Grants Call” and cannot be an applicant on a different application. Researchers who hold an active “Infectious Diseases Catalyst Grant” cannot apply until they are in the final year of their existing Catalyst grant, and the grant period for a new project cannot overlap with that of the active grant.
The project must be in scope of at least one of the two 2026 research themes and it must be use-inspired i.e., the research project must enhance fundamental knowledge and include considerations of potential application/translation of the knowledge gained towards generating better and needed tools. The scientific rationale, concept, and research direction should be driven by the potential use and/or translation of that knowledge.
The application should have clear aims/goals, and articulate the expected outcomes catalysed by this project, and the potential future impact of these outcomes beyond this project. The current clinical pipeline for tools to combat antimicrobial resistance (AMR) is inadequate and urgently requires new and innovative solutions.
Projects supported under this theme should investigate rationally designed and novel approaches to prevent, diagnose or treat antimicrobial resistant bacterial infections . Pathogens listed on the WHO Bacterial Priority Pathogen List, 2024 will be prioritised. Theme 2: Pandemic Influenza Pandemic influenza remains a substantial threat to public health.
There is an urgent need for a deeper understanding of the factors that influence viral infectivity, transmission, and disease severity in humans. Projects supported under this theme should address major research gaps in our understanding of pandemic influenza and interactions with the human host and aid the development of tools to prevent or combat infections effectively.
Out of scope : Projects which are mainly focused on surveillance, establishment/maintaining infrastructure (incl. databases and algorithms), clinical trial(s), microbiome research, phage therapy, as well as projects not directly related to human health. For-profit product development projects are ineligible.
A total of DKK 60 million is available for proposals in this call in 2026. The individual grants awarded can have one of two different granting frameworks: For each grant where there is only one applicant who is based in the Nordics, up to DKK 4 million can be awarded, with a grant period of up to 3 years.
For each grant where there is a Nordic main applicant and a co-applicant based in a different country, up to DKK 7 million can be awarded, with a grant period of up to 3 years. The budget does not have to be split evenly between the main and co-applicant institutions, but if one institution will receive significantly more funding, a clear justification must be provided.
The application must be completed and submitted using NNF’s online application and grant management system, NORMA, which can be accessed from: https://norma. novonordiskfonden. dk.
Applications will be assessed by the Committee for Infectious Diseases (CID) When all applications have been assessed, applicants will be notified if they have/ or have not been awarded a grant. The notification e-mail will be sent from norma. novonordiskfonden.
dk to the e-mail address entered on initial registration. For questions addressed in previous years regarding the call, please refer to the FAQ . NNF Kenya A/S Branch Office Studio 608 and 609, 6th floor NNF India A/S Branch Office Data Ethics and AI Policy Ethics in major construction Yes, I would like to receive relevant news from the Novo Nordisk Foundation.
Please enter a valid e-mail address
Based on current listing details, eligibility includes: Research institutions, biotech companies worldwide Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates $500,000 - $5 million Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is May 19, 2026. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
The Evidence for AI in Health (EVAH) initiative is a $60 million joint investment by the Gates Foundation, Novo Nordisk Foundation, and Wellcome Trust to support rigorous, country-led evaluations of AI health tools in low- and middle-income countries. Delivered in partnership with J-PAL and the African Population and Health Research Center, EVAH funds evaluations of AI-enabled clinical decision support tools in primary and community healthcare settings across Sub-Saharan Africa, South Asia, and Southeast Asia. Pathway A supports early-deployment evaluations focusing on usability, workflow integration, and safety for up to $1 million. Pathway B funds randomized controlled trials, economic analyses, and implementation science studies of tools ready for deployment at scale for up to $3 million. The initiative addresses a critical evidence gap about whether AI diagnostic and clinical decision support tools actually improve health outcomes in resource-limited settings.
Novo Nordisk Foundation Data Science Investigator Programme is a grant from the Novo Nordisk Foundation that funds research leaders in data science at Danish universities and nonprofit research institutions. The program offers awards of up to DKK 14.7 million per grant over five years and targets three career levels: Emerging, Ascending, and Distinguished, based on years post-PhD. Applicants must be employed at a Danish university or non-profit research institution. The 2026 application deadline is July 15, 2026. All applicants must carefully review the combined Application Guidelines for their career stage before initiating their application in the foundation's grant portal.